Brain Biomarker Reference Levels in Healthy Newborns
Part of Brain & nervous system clinical trials.
This study collects blood samples and health information from healthy full-term newborns to establish normal ranges for brain-related markers in early life. Understanding these baseline levels may help doctors better identify babies who need extra care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born at 37 weeks of pregnancy or later (full-term)
- A routine blood sample can be drawn within the first week of life
- You have medical records with your baby's birth details (weight, delivery method, health score at birth)
- Your baby has no signs of brain, nervous system, or genetic conditions
- Your baby was not admitted to the neonatal intensive care unit (NICU)
- Your baby shows no signs of serious infection or blood poisoning
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a substance in the blood called neurofilaments, which may help doctors understand early brain development in babies born a few weeks early. If your baby already needs a blood test, researchers will use a small extra sample to learn more.
This study enrolls newborns (within the first 28 days of life) who have specific brain or nervous system conditions. It tests how these conditions are tracked and studied, which may help improve care and understanding over time.
This study looks at biomarkers (biological signs) in infants who had a brain injury around birth or were born very early, and compares them with healthy babies. The goal is to learn more about brain injuries and recovery.
This study uses a safe, non-invasive ultrasound technique to measure brain activity in newborn babies. It aims to understand brain development and connectivity in preterm infants, infants with birth-related oxygen deprivation, growth-restricted babies, siblings of children with autism, and healthy full-term babies.
This study looks at a special blood marker in full-term newborns who had brain injury from lack of oxygen during birth. It aims to help doctors better understand and treat this condition.
This study uses a safe, painless ultrasound to measure blood flow in the brains of newborns (both full-term and preterm) in the first 48 hours after birth. The goal is to understand how blood flow differs in these babies, which may help improve care.
Hear when a new Biomarker in Early Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.